Medicine Safety Insight

The Cost of Missing Safety Signals

Patient safety depends on recognising and responding to medicine-related problems as early as possible. When safety signals are missed, preventable harm can continue unnoticed, affecting many more patients before any action is taken.

One of the most common reasons safety signals are missed is incomplete documentation. Missing information on medicines, doses, symptom timing, or patient history makes it difficult to determine whether a medicine contributed to an adverse event.

Another challenge is the underreporting of adverse drug reactions. Many suspected reactions go unreported because they seem mild, are considered expected, or there is uncertainty about the link between the medicine and the event. However, pharmacovigilance depends on collecting many individual reports to identify patterns that might otherwise remain invisible.

Missing safety signals can have serious consequences. Harmful medicines may continue to be prescribed without adequate warnings, healthcare professionals may remain unaware of emerging risks, and patients may experience preventable adverse events.

Improving documentation and encouraging timely reporting strengthen healthcare systems’ ability to detect safety concerns early. Every accurate patient record and every ADR report contribute to a safer environment in which lessons learned from one patient help protect many others.